Business · Companies · 29 mins ago

Mayne Pharma agrees to $6.40-a-share takeover by Gedeon Richter

Mayne Pharma agrees to $6.40-a-share takeover by Gedeon Richter

Mayne Pharma has agreed to a cash takeover offer from Gedeon Richter at $6.40 per share.

The Australian drug company’s shares closed at $3.21 on Monday and rose to $5.71 in early trading on Tuesday.

The Mayne board unanimously recommends the offer, and three of the company’s largest shareholders have said they will sell their shares into the deal.

Richter is a specialty drug company founded in Hungary, with operations in about 50 countries.

The offer values Mayne’s equity at about $604 million and follows an earlier bid by US company Cosette, which tried to withdraw before losing a court case and an appeal.

The takeover requires approval from Mayne shareholders and Australia’s foreign investment regulator, as well as a positive recommendation from an independent expert.

Mayne’s board says it would consider a better offer if one emerges before the deal is completed.

2 sources

Related

What people are saying

Bruce RobinsonMayne Pharma chair
The Board has carefully considered the proposal from Richter and has unanimously concluded that it is in the best interests of Mayne Pharma shareholders, in the absence of a Superior Proposal and subject to the Independent Expert's conclusion.
via Motley Fool AU
to realise value at a significant premium to recent trading prices
via Stockhead
continue to pursue its claims against Cosette, Cosette Pharmaceuticals Holdings, Inc, and its controllers, Mr David Burghstahler and Avista Capital for damages on behalf of itself and Mayne Pharma shareholders
via Motley Fool AU
Mayne PharmaCompany statement, as quoted by Motley Fool AU
no Mayne Material Adverse Change had occurred and that Mayne Pharma did not engage in misleading and deceptive conduct regarding its FY25 EBITDA financial performance
via Motley Fool AU